SE389331B - Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. - Google Patents

Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.

Info

Publication number
SE389331B
SE389331B SE7204544A SE454472A SE389331B SE 389331 B SE389331 B SE 389331B SE 7204544 A SE7204544 A SE 7204544A SE 454472 A SE454472 A SE 454472A SE 389331 B SE389331 B SE 389331B
Authority
SE
Sweden
Prior art keywords
methylendiphenols
procedure
preparation
certain stated
stated
Prior art date
Application number
SE7204544A
Other languages
English (en)
Inventor
Samuel Van Der Meer
Hendrikus Matheus Van Alphen
Original Assignee
Acf Chemiefarma Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acf Chemiefarma Nv filed Critical Acf Chemiefarma Nv
Publication of SE389331B publication Critical patent/SE389331B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/26—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups and being further substituted by halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE7204544A 1971-04-09 1972-04-07 Forfarande for framstellning av vissa angivna 2,2-metylendifenoler. SE389331B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7104839.A NL167151C (nl) 1971-04-09 1971-04-09 Werkwijze ter bereiding van geneesmiddelen met anti-parasitaire werking op basis van halogeen bevatten- de 2,2'-methyleendifenolderivaten, alsmede werkwijze ter bereiding van deze geneeskrachtige verbindingen.

Publications (1)

Publication Number Publication Date
SE389331B true SE389331B (sv) 1976-11-01

Family

ID=19812895

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7204544A SE389331B (sv) 1971-04-09 1972-04-07 Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.

Country Status (19)

Country Link
US (1) US3884906A (sv)
JP (2) JPS5525177B1 (sv)
AR (2) AR194587A1 (sv)
AU (1) AU459272B2 (sv)
BE (1) BE781674A (sv)
CH (2) CH575372A5 (sv)
DE (1) DE2215409C3 (sv)
DK (1) DK143227C (sv)
ES (1) ES401501A1 (sv)
FR (1) FR2132788B1 (sv)
GB (1) GB1346266A (sv)
HU (1) HU165790B (sv)
IE (1) IE36209B1 (sv)
IL (1) IL39108A (sv)
NL (1) NL167151C (sv)
PH (2) PH15268A (sv)
SE (1) SE389331B (sv)
SU (1) SU580828A3 (sv)
ZA (1) ZA722331B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4101678A (en) * 1977-11-08 1980-05-01 Ici Australia Ltd Process for killing parasites
FR2549476B1 (fr) * 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
RS52365B (en) * 2004-03-16 2012-12-31 Boehringer Ingelheim International Gmbh BENZOL DERIVATIVES SUBSTITUTED BY GLUCOPYRANOSIL, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS, THEIR USE AND THE PROCEDURE FOR THEIR PRODUCTION
UA91546C2 (uk) * 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
US7772191B2 (en) * 2005-05-10 2010-08-10 Boehringer Ingelheim International Gmbh Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
CL2008002427A1 (es) * 2007-08-16 2009-09-11 Boehringer Ingelheim Int Composicion farmaceutica que comprende 1-cloro-4-(b-d-glucopiranos-1-il)-2-[4-((s)-tetrahidrofurano-3-iloxi)bencil]-benceno combinado con 1-[(4-metilquinazolin-2-il)metil]-3-metil-7-(2-butin-1-il)-8-(3-(r)-aminopiperidin-1-il)xantina; y su uso para tratar diabetes mellitus tipo 2.
WO2009068617A1 (en) * 2007-11-30 2009-06-04 Boehringer Ingelheim International Gmbh 1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a modulators for the teatment of cns disorders
UA105362C2 (en) * 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
PE20110383A1 (es) 2008-09-08 2011-07-15 Boehringer Ingelheim Int Pirazolopirimidinonas como inhibidores de la fosfodiesterasa 9a (pde9a)
ES2982194T3 (es) * 2009-02-13 2024-10-15 Boehringer Ingelheim Int Composición farmacéutica que comprende derivados de glucopiranosilo, difenilmetano, forma de dosificación farmacéutica de la misma, proceso para su preparación y usos de la misma para el control glucémico mejorado en un paciente
PL2395983T3 (pl) 2009-02-13 2020-09-07 Boehringer Ingelheim International Gmbh Kompozycja farmaceutyczna zawierająca inhibitor sglt2, inhibitor dpp-iv i ewentualnie dalszy środek przeciwcukrzycowy oraz jej zastosowania
GEP20146098B (en) 2009-03-31 2014-05-27 Boehringer Ingelheim Int 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their usage as pde9a modulators
AR077859A1 (es) * 2009-08-12 2011-09-28 Boehringer Ingelheim Int Compuestos para el tratamiento de trastornos del snc
KR101813025B1 (ko) 2009-09-30 2017-12-28 베링거 인겔하임 인터내셔날 게엠베하 글루코피라노실­치환된 벤질­벤젠 유도체의 제조방법
PH12012500633B1 (en) * 2009-09-30 2017-12-13 Boehringer Ingelheim Int Method for the preparation of a crystalline form of 1-chloro -4- (beta -d- glucopyranos -1-yl) -2- (4-((s)- tetrahydrofuran -3- yloxy) benzyl) benzene
US10610489B2 (en) * 2009-10-02 2020-04-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
CN105541849B (zh) 2010-08-12 2018-03-23 勃林格殷格翰国际有限公司 6‑环烷基‑1,5‑二氢‑吡唑并[3,4‑d]嘧啶‑4‑酮衍生物及其作为PDE9A抑制剂的用途
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
AR085689A1 (es) 2011-03-07 2013-10-23 Boehringer Ingelheim Int Composiciones farmaceuticas de metformina, linagliptina y un inhibidor de sglt-2
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US9192617B2 (en) 2012-03-20 2015-11-24 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
ES2702174T3 (es) 2013-04-05 2019-02-27 Boehringer Ingelheim Int Usos terapéuticos de empagliflozina
US20140303097A1 (en) 2013-04-05 2014-10-09 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en) 2013-04-05 2023-11-14 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
SI2986304T1 (sl) 2013-04-18 2022-04-29 Boehringer Ingelheim International Gmbh Farmacevtski sestavek, postopki za zdravljenje in njegove uporabe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2544826A (en) * 1945-05-08 1951-03-13 Dow Chemical Co Anthelmintic feed composition
US2615052A (en) * 1950-06-23 1952-10-21 Allied Lab Inc 2,2'-methylenebis(4-chloro-6-nitrophenol) and a method for its production
US2739941A (en) * 1952-09-13 1956-03-27 Gen Aniline & Film Corp Germicidal soap composition
NL283922A (sv) * 1962-10-03

Also Published As

Publication number Publication date
AR193590A1 (es) 1973-04-30
AU459272B2 (en) 1975-03-05
FR2132788A1 (sv) 1972-11-24
US3884906A (en) 1975-05-20
JPS5950645B2 (ja) 1984-12-10
NL167151C (nl) 1981-11-16
ES401501A1 (es) 1975-02-16
CH575372A5 (sv) 1976-05-14
JPS557256A (en) 1980-01-19
IE36209B1 (en) 1976-09-15
BE781674A (fr) 1972-10-05
IL39108A (en) 1976-04-30
IE36209L (en) 1972-10-09
AR194587A1 (es) 1973-07-31
GB1346266A (en) 1974-02-06
PH15268A (en) 1982-11-02
FR2132788B1 (sv) 1976-05-14
HU165790B (sv) 1974-11-28
PH14191A (en) 1981-03-26
NL167151B (nl) 1981-06-16
DE2215409C3 (de) 1980-10-09
ZA722331B (en) 1973-01-31
DE2215409B2 (de) 1980-02-14
JPS5525177B1 (sv) 1980-07-04
IL39108A0 (en) 1972-05-30
DK143227B (da) 1981-07-27
CH586182A5 (sv) 1977-03-31
DK143227C (da) 1981-11-30
AU4085072A (en) 1973-10-11
NL7104839A (sv) 1972-10-11
DE2215409A1 (de) 1973-01-25
SU580828A3 (ru) 1977-11-15

Similar Documents

Publication Publication Date Title
SE389331B (sv) Forfarande for framstellning av vissa angivna 2,2-metylendifenoler.
SE384211B (sv) Forfarande for framstellning av 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
FI55186B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1,4-dihydropyridinkarboxylsyraestrar
NO147916C (no) Fremgangsmaate for fremstilling av 3-metylen-cefalosporin-forbindelser.
BG20336A3 (bg) Метод за получаване на 3-карбомоил-2.4.6- трийдефинил-алкилетери
SE7505279L (sv) Forfarande for framstellning av hydroxipyrimidiner.
BG19799A3 (bg) Метод за получаване на 3,4-дихидро-2н-изохинолин-1-они
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE386175B (sv) Forfarande for framstellning av 1,4-bis-acylpiperaziner
SE406587B (sv) Forfarande for framstellning av 4-hydroximetyl-1-keto-1,2-dihydroftalazin
NO137093C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner
SE394677B (sv) Forfarande for framstellning av 4-hydroxi-2h-1-bensotiopyran-3-karboxanilid-1,1-dioxider
SE390025B (sv) Forfarande for framstellning av 3 alfa-hydroxi-19-5 alfa-pregnan-11,20-dion
NO136046C (no) Fremgangsm}te til fremstilling av 2,4-diamino-5-benzylpyrimidiner.
SE383521B (sv) Forfarande for framstellning av kardenolid-3-(2',3-dedesoxi-2,'3'-oxido-glykosider).
SE400548B (sv) Forfarande for framstellning av en substituerad bensoylester av en 1,8,9-trihydroxiantracen
NO136195C (no) Fremgangsm}te ved fremstilling av 2,4-diamino-5-benzylpyrimidiner.
DK130308B (da) Fremgangsmåde til fremstilling af 13β-alkylgona-4,9,11-triener.
SE389103B (sv) Forfarande for framstellning av 1,4-metano-och 1,4-etanotetrahydro
SE389335B (sv) Forfarande for framstellning av vissa angivna ketaziner.
SE401366B (sv) Forfarande for framstellning av 2,6-metano-3-bensazociner
DK131189B (da) Analogifremgangsmåde til fremstilling af 16-hydroxylerede 17alfa-ethynyl-17beta-hydroxy-13beta-alkylgona-4,9,11-trien-3-oner.
NO138140C (no) Fremgangsmaate for fremstilling av 4,4`-ditert.butyl-benzoylperoksyd
DK134518B (da) Analogifremgangsmåde til fremstilling af 4beta-alkoxy-4alfa-(3'-hydroxyphenyl)-3alfa,5alfa-propanopiperidin-derivater.
NO137940C (no) Analogifremgangsmaate til fremstilling av 4`,5-dinitro-3`-trifluormetyl-2-tiofenanilid